CNCR
ETF Series Solutions Trust Range Cancer Therapeutics ETF
CNCR
CNCR
Delisted
CNCR was delisted on the 27th of May, 2025.
23 hedge funds and large institutions have $12.5M invested in ETF Series Solutions Trust Range Cancer Therapeutics ETF in 2018 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 8 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
71% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 7
Holders
23
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$438K | |
| 2 | +$376K | |
| 3 | +$248K | |
| 4 |
OC
Oppenheimer & Co
New York
|
+$201K |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$85.1K |
Top Sellers
| 1 | -$342K | |
| 2 | -$332K | |
| 3 | -$329K | |
| 4 |
PCM
Prelude Capital Management
New York
|
-$291K |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$287K |